BAMCO Inc’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$75.7M Sell
778,425
-339,253
-30% -$29.7M 0.13% 80
2026
Q2
$92.8M Sell
1,117,678
-12,375
-1% -$672K 0.14% 73
2026
Q1
$43.6M Buy
1,130,053
+130,483
+13% +$5.42M 0.13% 128
2025
Q4
$46.4M Buy
999,570
+54,595
+6% +$2.63M 0.13% 142
2025
Q3
$46.4M Sell
944,975
-787
-0.1% -$41.2K 0.12% 144
2025
Q2
$48.9M Buy
+945,762
New +$38.2M 0.13% 139

Other funds holding HNGE

BAMCO Inc's HNGE Position: Q3 2026 in Review

BAMCO Inc reduced its Hinge Health (HNGE) stake by 30% in Q3 2026, selling an estimated $29.7M and leaving 778,425 shares worth $75.7M. The position accounts for 0.13% of the portfolio, ranked #80.

BAMCO Inc first reported a position in HNGE in Q2 2025 and has held it in 6 quarters since. The position peaked at $92.8M in Q2 2026. 367 funds tracked by Wall St. Rank hold HNGE as of Q3 2026.

  • BAMCO Inc held 778,425 shares of Hinge Health worth $75.7M as of Q3 2026.
  • BAMCO Inc sold 339,253 Hinge Health shares in Q3 2026, an estimated $29.7M.
  • Hinge Health made up 0.13% of BAMCO Inc's portfolio in Q3 2026, its #80 holding.
  • BAMCO Inc first reported a position in Hinge Health in Q2 2025 and has held it in 6 quarters since.
  • BAMCO Inc's Hinge Health position peaked at $92.8M in Q2 2026.
  • 367 funds tracked by Wall St. Rank held Hinge Health as of Q3 2026.

Based on BAMCO Inc's 13F filing for Q3 2026, filed 16 Nov 2026.